(EN)
Humanized antibodies are provided that specifically bind HLA-DR. The
antibodies recognize the epitope recognized by the murine monoclonal antibody
L243. Processes for preparing such antibodies, pharmaceutical compositions
containing such antibodies, and clinical therapuetic and diagnostic, as well
as research-related uses for such antibodies, are provided.